Results 21 to 30 of about 3,130,322 (229)

Survival Impact of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer in an Asian Population

open access: yesOman Medical Journal, 2015
Objective: The aim of this study was to evaluate the role of secondary cytoreductive surgery in Asian patients with recurrent ovarian cancer and to assess prognostic variables on overall post-recurrence survival time.
Rani Akhil Bhat   +5 more
doaj   +1 more source

A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

open access: yesBMC Cancer, 2017
Background This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). Methods Patients
Kyung Jin Eoh   +6 more
doaj   +1 more source

Aggressive cytoreduction and multiple subpial cortical transections may obtain good surgical outcomes in refractory epilepsy with multiple epileptic foci

open access: yesBiomedical Journal, 2020
Backgrounds Epilepsy surgery is the most efficacious therapeutic modality for patients with medical refractory epilepsy, especially resective surgery. However, the variable etiologies and multiple epileptic foci are usually associated with the outcomes ...
Hsiang-Yao Hsieh   +12 more
semanticscholar   +1 more source

Guidelines from the Polish Surgical Society and Polish Society of Oncological Surgery Concerning Quality Assurance for Centres Performing Cytoreductive Procedures and HIPEC Procedures in the Treatment of Primary and Secondary Peritoneal Tumours

open access: yesNowotwory. Journal of Oncology, 2020
Surgical treatment of patients with peritoneal metastases in combination with Hyperthermic intraperitoneal Chemotherapy (HIPEC) and systemic treatments is applied with increasing frequency and, with correct patient qualification, allows for obtaining 5-year survival at a level of 32–52%.
Tomasz Jastrzębski   +20 more
openaire   +3 more sources

Preliminary Experience and Morbidity Analysis of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/Hipec) from a Tertiary Cancer Center in India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Background: Peritoneal carcinomatosis (PC) can arise directly from peritoneum (primary) or from regional spread of gastrointestinal and gynecological malignancies. It is often considered a terminal event.
Naveen Padmanabhan   +4 more
doaj   +1 more source

83 Impact of introducing extensive surgical procedures to cytoreductive surgery (CRS) in advanced epithelial ovarian cancer (EOC) on rate of complete debulking (CD) and survival [PDF]

open access: yesInternational Journal of Gynecological Cancer, 2019
Objectives To asses the impact of extensive procedures (Diaphragmatic resection, large and small bowel resection, complete peritonectomy, complete omentectomy, paraaortic lmph node dissection, splenectomy, resection of all visible disease) in CRS on the rate of CD, progression free (PFS), and overall survival (OS) in patients with advanced EOC ...
M. Seoud   +6 more
openaire   +1 more source

Impact of proper surgical treatment on the survival of patients with epithelial ovary cancer

open access: yesRevista do Colégio Brasileiro de Cirurgiões, 2022
Objective: to evaluate the quality of surgical treatment of ovarian cancer patients and assess the impact of adequate surgical oncological treatment on disease-free survival and overall survival of patients with advanced epithelial ovarian cancer ...
FLAVIO HENRIQUE FARIA   +3 more
doaj   +2 more sources

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

open access: yesRevista do Colégio Brasileiro de Cirurgiões, 2023
Peritoneal carcinomatosis (PC) indicates advanced stage cancer, which is generally associated with a poor outcome and a 6 to 12 months. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an option for treating patients ...
JAIRO SEBASTIÁN ASTUDILLO VALLEJO   +7 more
doaj   +2 more sources

A proposal of Brazilian Society of Surgical Oncology (BSSO/SBCO) for standardizing cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma [PDF]

open access: yesRevista do Colégio Brasileiro de Cirurgiões, 2017
ABSTRACT Cytoreductive surgery plus hypertermic intraperitoneal chemotherapy has emerged as a major comprehensive treatment of peritoneal malignancies and is currently the standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome as well as malignant peritoneal mesothelioma.
Batista, Thales Paulo   +15 more
openaire   +4 more sources

Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence [PDF]

open access: yes, 2023
The reiteration of surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients affected by recurrent peritoneal metastases is still questioned regarding safety and effectiveness.
Robella, Manuela   +50 more
core   +2 more sources

Home - About - Disclaimer - Privacy